Omega Healthcare Investors Inc (OHI)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $14.97B
Last updated: Nov 17, 2026 at 11:06 AM ET
Omega Healthcare Investors Inc (OHI) Earnings: Report Dates and Results
FFO per share for Omega Healthcare Investors (OHI) was $3.09 for 2025. In the quarter ended Sep 30, 2026, Omega Healthcare Investors reported EPS of $0.82, above the $0.78 estimate. It beat the EPS estimate in 5 of the last 8 quarters. Omega Healthcare Investors is expected to report earnings on Feb 2, 2027.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
OHI has an expected report date of Feb 2, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 9.4% below the $0.53 reported for the quarter ended Dec 31, 2025.
OHI Earnings Call
The latest OHI earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, OHI beat 18, missed 21 and matched 1. The widest gap in the table came in the quarter ended Sep 30, 2020, when EPS landed 350.00% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.82 | $0.78 | N/A | +5.13% | Beat | +39.0% | 4 | 0 up, 1 down | Nov 3, 2026 | N/A |
| Jun 30, 2026 | $0.83 | $0.77 | N/A | +7.79% | Beat | +66.0% | 2 | 0 up, 0 down | Jul 29, 2026 | $526.65M |
| Mar 31, 2026 | $0.48 | $0.49 | $0.49 - $0.49 | -2.04% | Miss | +17.1% | 1 | 0 up, 1 down | Apr 28, 2026 | $276.22M |
| Dec 31, 2025 | $0.53 | $0.50 | $0.49 - $0.52 | +6.00% | Beat | +32.5% | 2 | 0 up, 0 down | Feb 4, 2026 | $229.13M |
| Sep 30, 2025 | $0.59 | $0.45 | $0.44 - $0.46 | +31.11% | Beat | +25.5% | 2 | 0 up, 0 down | Oct 30, 2025 | $281.75M |
| Jun 30, 2025 | $0.50 | $0.41 | $0.40 - $0.42 | +21.95% | Beat | +6.4% | 2 | 0 up, 0 down | Jul 31, 2025 | $252.50M |
| Mar 31, 2025 | $0.41 | $0.46 | $0.46 - $0.46 | -10.87% | Miss | +36.7% | 1 | 2 up, 0 down | May 1, 2025 | $234.58M |
| Dec 31, 2024 | $0.40 | $0.41 | $0.41 - $0.42 | -2.44% | Miss | +60.0% | 2 | 1 up, 0 down | Feb 5, 2025 | $225.96M |
| Sep 30, 2024 | $0.47 | $0.40 | N/A | +17.50% | Beat | +2.2% | 6 | 0 up, 0 down | Oct 30, 2024 | $221.10M |
| Jun 30, 2024 | $0.47 | $0.36 | $0.33 - $0.38 | +30.56% | Beat | +42.4% | 6 | 0 up, 0 down | Aug 1, 2024 | $211.69M |
| Mar 31, 2024 | $0.30 | $0.30 | $0.27 - $0.36 | 0.00% | In line | -3.2% | 6 | 0 up, 0 down | May 2, 2024 | $184.09M |
| Dec 31, 2023 | $0.25 | $0.32 | $0.28 - $0.49 | -21.88% | Miss | -37.5% | 7 | 0 up, 0 down | Feb 7, 2024 | $258.53M |
| Sep 30, 2023 | $0.46 | $0.43 | N/A | +6.98% | Beat | +2.2% | 7 | 0 up, 1 down | Nov 2, 2023 | $183.25M |
| Jun 30, 2023 | $0.33 | $0.51 | N/A | -35.29% | Miss | -21.4% | 6 | 0 up, 0 down | Aug 2, 2023 | $192.44M |
| Mar 31, 2023 | $0.31 | $0.58 | N/A | -46.55% | Miss | -61.7% | 6 | 1 up, 0 down | May 2, 2023 | $159.66M |
| Dec 31, 2022 | $0.40 | $0.32 | $0.32 - $0.91 | +25.00% | Beat | +185.7% | 5 | 0 up, 0 down | Feb 2, 2023 | $296.15M |
| Sep 30, 2022 | $0.45 | $0.53 | N/A | -15.09% | Miss | -23.7% | 4 | 0 up, 0 down | Nov 2, 2022 | $222.12M |
| Jun 30, 2022 | $0.42 | $0.58 | N/A | -27.59% | Miss | +10.5% | 7 | 1 up, 0 down | Aug 1, 2022 | $181.87M |
| Mar 31, 2022 | $0.81 | $0.44 | N/A | +84.09% | Beat | +62.0% | 7 | 0 up, 0 down | May 2, 2022 | $304.81M |
| Dec 31, 2021 | $0.14 | $0.54 | $0.40 - $0.64 | -74.07% | Miss | -67.4% | 6 | 0 up, 0 down | Feb 2, 2022 | $30.51M |
| Sep 30, 2021 | $0.59 | $0.43 | $0.41 - $0.45 | +37.21% | Beat | N/A | 7 | N/A | Nov 4, 2021 | $278.86M |
| Jun 30, 2021 | $0.38 | $0.39 | $0.34 - $0.46 | -2.56% | Miss | -19.1% | 5 | N/A | Aug 2, 2021 | $202.66M |
| Mar 31, 2021 | $0.50 | $0.45 | $0.42 - $0.47 | +11.11% | Beat | +25.0% | 5 | N/A | May 3, 2021 | $315.59M |
| Dec 31, 2020 | $0.43 | $0.37 | $0.26 - $0.46 | +16.22% | Beat | +2.4% | 6 | N/A | Feb 4, 2021 | $45.72M |
| Sep 30, 2020 | -$0.27 | -$0.06 | N/A | -350.00% | Miss | -142.9% | 4 | N/A | Oct 29, 2020 | $118.28M |
| Jun 30, 2020 | $0.47 | $0.43 | $0.30 - $0.48 | +9.30% | Beat | +30.6% | 5 | N/A | Aug 5, 2020 | $269.24M |
| Mar 31, 2020 | $0.40 | $0.42 | $0.41 - $0.43 | -4.76% | Miss | +5.3% | 3 | N/A | May 4, 2020 | $254.86M |
| Dec 31, 2019 | $0.42 | $0.39 | N/A | +7.69% | Beat | +13.5% | 2 | N/A | Feb 5, 2020 | $239.86M |
| Sep 30, 2019 | $0.63 | $0.40 | $0.39 - $0.43 | +57.50% | Beat | +70.3% | 3 | N/A | Nov 5, 2019 | $183.32M |
| Jun 30, 2019 | $0.36 | $0.38 | $0.34 - $0.39 | -5.26% | Miss | -2.7% | 3 | N/A | Aug 6, 2019 | $176.71M |
| Mar 31, 2019 | $0.38 | $0.40 | N/A | -5.00% | Miss | +8.6% | 2 | N/A | May 7, 2019 | $175.93M |
| Dec 31, 2018 | $0.37 | $0.43 | N/A | -13.95% | Miss | -39.3% | 1 | N/A | Feb 11, 2019 | $196.93M |
| Sep 30, 2018 | $0.37 | $0.40 | $0.37 - $0.40 | -7.50% | Miss | -17.8% | 4 | N/A | Nov 5, 2018 | $150.01M |
| Jun 30, 2018 | $0.37 | $0.38 | $0.36 - $0.39 | -2.63% | Miss | +2.8% | 4 | N/A | Aug 3, 2018 | $170.00M |
| Mar 31, 2018 | $0.35 | $0.36 | $0.35 - $0.38 | -2.78% | Miss | -23.9% | 5 | N/A | May 7, 2018 | $188.09M |
| Dec 31, 2017 | $0.61 | $0.42 | $0.40 - $0.44 | +45.24% | Beat | 0.0% | 4 | N/A | Feb 13, 2018 | $268.52M |
| Sep 30, 2017 | $0.45 | $0.46 | $0.36 - $0.49 | -2.17% | Miss | -6.2% | 4 | N/A | Oct 30, 2017 | $220.33M |
| Jun 30, 2017 | $0.36 | $0.49 | $0.48 - $0.50 | -26.53% | Miss | -39.0% | 4 | N/A | Jul 26, 2017 | $235.18M |
| Mar 31, 2017 | $0.46 | $0.50 | N/A | -8.00% | Miss | 0.0% | N/A | N/A | May 3, 2017 | $239.16M |
| Dec 31, 2016 | $0.61 | $0.48 | N/A | +27.08% | Beat | +84.8% | N/A | N/A | Feb 8, 2017 | $1.06B |
Annual FFO
FFO per share was $3.09 for 2025, up 4.7% from $2.95 in 2024. It was $2.52 for 2016, the oldest of the 10 years shown.
| Fiscal year | FFO per share | Change |
|---|---|---|
| 2025 | $3.09 | +4.7% |
| 2024 | $2.95 | -1.3% |
| 2023 | $2.99 | -9.7% |
| 2022 | $3.31 | +2.5% |
| 2021 | $3.23 | +12.2% |
| 2020 | $2.88 | -5.3% |
| 2019 | $3.04 | -7.9% |
| 2018 | $3.30 | +0.9% |
| 2017 | $3.27 | +29.8% |
| 2016 | $2.52 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $2.03, up 23.8% from the year before. It was $2.14 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $2.03 | +23.8% |
| Dec 31, 2024 | $1.64 | +21.5% |
| Dec 31, 2023 | $1.35 | -35.1% |
| Dec 31, 2022 | $2.08 | +29.2% |
| Dec 31, 2021 | $1.61 | +56.3% |
| Dec 31, 2020 | $1.03 | -42.5% |
| Dec 31, 2019 | $1.79 | +22.6% |
| Dec 31, 2018 | $1.46 | -22.3% |
| Dec 31, 2017 | $1.88 | -12.1% |
| Dec 31, 2016 | $2.14 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,000 words across 17 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,023 | 17 | |
| 2026Q2 | Jun 30, 2026 | 8,454 | 21 | |
| 2026Q1 | Mar 31, 2026 | 7,077 | 22 | |
| 2025Q4 | Dec 31, 2025 | 7,362 | 18 | |
| 2025Q3 | Sep 30, 2025 | 7,695 | 19 | |
| 2025Q2 | Jun 30, 2025 | 5,715 | 16 | |
| 2025Q1 | Mar 31, 2025 | 5,232 | 18 | |
| 2024Q4 | Dec 31, 2024 | 5,761 | 16 |
2026Q3 Earnings Call
Opening remarks
Michele Reber Moderator Thank you, and good morning. With me today is Omega's CEO, Matthew Gourmand; CFO, Neal Alexander Ballew; CIO, Vikas Gupta; and Megan Krull, Senior Vice President of Data, Intelligence, and Government Relations. Comments made during this conference call that are not historical facts may be forward-looking statements, such as statements regarding our financial projections, potential transactions, operator prospects, and outlook generally. Factors that could cause actual results to differ materially from those in the forward-looking statements are detailed in the company's filings with the SEC. During the call today, we will refer to some non-GAAP financial measures, such as NAREIT FFO, adjusted FFO, FAD, and EBITDA. Reconciliations of these non-GAAP measures to the most comparable measure under generally accepted accounting principles are available in the quarterly supplement. In addition, certain operator coverage and financial information that we discuss is based on data provided by our operators that has not been independently verified by Omega. I will now turn the call over to Matthew.
Matthew Gourmand CEO Thanks, Michele. Good morning, and thank you for joining our third quarter 2026 earnings conference call. Today, I will discuss our third quarter financial results, as well as some of our recent transactions. Third quarter adjusted funds from operations, or AFFO, of $0.82 per share and FAD, or funds available for distribution, of $0.78 per share reflect solid year-over-year growth. However, it should be noted that sequentially, these financial metrics were effectively flat, driven by the headwind from $563 million of asset sales late in the second quarter. However, as we have been at pains to stress in our discussions with investors, we are managing this business to create long-term sustainable value. We believe these dispositions, which were sold at an effective 7 cap rate on cash flow, allowed us to exit assets that were going to require significant capital investment over the longer term while strengthening the underlying credit support of the related operators. This is an example of the active portfolio management that we have spoken about in recent quarters. We were able to show another example in the third quarter as we transitioned 32 facilities to PACS, paying a $90 million termination fee to the prior operator and increasing annual cash rents on this portfolio by $26.1 million in the first year, an effective yield of 29%. This highly accretive transaction addressed the needs of two longstanding operators while supporting continued quality of care for residents. We believe there are selective opportunities to achieve similar strong accretion through further active portfolio management efforts in the coming quarters.
Frequently Asked Questions About OHI
When is Omega Healthcare Investors's next earnings date?
Omega Healthcare Investors's next earnings report is expected for Feb 2, 2027.
Did OHI beat earnings estimates last quarter?
Yes. Omega Healthcare Investors reported EPS of $0.82 for the quarter ended Sep 30, 2026, above the $0.78 estimate, a 5.13% surprise.
What EPS do analysts expect from OHI next quarter?
The consensus EPS estimate for Omega Healthcare Investors for the quarter ending Dec 31, 2026 is $0.48 from 6 analysts, with estimates from $0.44 to $0.53.
How often does OHI beat earnings estimates?
Omega Healthcare Investors beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +7.08%.
OHI pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors